Ravi Salgia to Bone Neoplasms
This is a "connection" page, showing publications Ravi Salgia has written about Bone Neoplasms.
Connection Strength
0.096
-
Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation. Nat Clin Pract Oncol. 2006 Jan; 3(1):50-7; quiz 1 p following 57.
Score: 0.056
-
Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer. Eur J Cancer Prev. 2001 Feb; 10(1):77-82.
Score: 0.040